Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00106821 · ClinicalTrials.gov registry record · Phase 4
Efficacy of Tiotropium in Patients of African Descent With Chronic Obstructive Pulmonary Disease
A Phase 4 study, sponsored by Boehringer Ingelheim.
- Completed
- Registry status
- Phase 4
- Development phase
- 166
- Enrollment target
NCT00106821: Completed Phase 4 study, sponsored by Boehringer Ingelheim.
NCT00106821 is a Phase 4 study that has completed, run by Boehringer Ingelheim. The registered enrollment target is 166 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (68% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00106821, a Phase 4 study, has completed, sponsored by Boehringer Ingelheim.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 166 participants
- Enrollment target
Study Summary
The purpose of this study is to look at the benefits of tiotropium, an approved drug for the treatment of bronchospasm associated with COPD (chronic obstructive pulmonary disease), in a population of patients with COPD who are of African American descent.
Interventions
- DRUG Tiotropium Bromide Inhalation Powder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 166 participants |
| Start Date | 2004-06 |
| Phase | Phase 4 |
What the finished NCT00106821 record still lists
NCT00106821 is an interventional study that assigns participants to a tested intervention. The registered 166 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (68% lower).
The record links to 0 conditions, and to 1 intervention - of which Tiotropium Bromide Inhalation Powder is the first listed.
NCT00106821 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00106821 about?
NCT00106821 is a clinical study titled "Efficacy of Tiotropium in Patients of African Descent With Chronic Obstructive Pulmonary Disease". The purpose of this study is to look at the benefits of tiotropium, an approved drug for the treatment of bronchospasm associated with COPD (chronic obstructive pulmonary disease), in a population of patients with COPD who are of African American descent.
What is the current status of trial NCT00106821?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 166 participants. The study started on 2004-06.
What interventions are being tested in trial NCT00106821?
The interventions under investigation include: Tiotropium Bromide Inhalation Powder (DRUG).
Who is sponsoring clinical trial NCT00106821?
This trial is sponsored by Boehringer Ingelheim, which has 515 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00106821's enrollment target sits among peer trials
166 489th of 2000 higher than 1,509 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02747303 · 166 participants · Phase 2
Frameless Stereotactic Radiosurgery for Intact Brain Metastases
- NCT03806283 · 166 participants
Mechanisms of Pregnancy Vascular Adaptations
- NCT04040452 · 166 participants · Phase 4
Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery
- NCT04375813 · 166 participants · Phase 2
Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia